Table 7.

Compiled characterization of tobramycin sulphate loaded chitosan nanoparticles.

S. No.	Formulations	Average particle size ± S.D	Zeta Potential ± S.D	Polydispersity Index ± S.D	Entrapment Efficiency ± S.D
1	F1	85.63 ± 2.13	21.64 ± 1.64	0.522 ± 1.31	78.381 ± 0.73
2	F2	79.82 ± 1.48	35.74 ± 0.95	0.426 ± 1.84	86.382 ± 1.29
3	F3	109.32 ± 1.73	22.26 ± 0.53	6.379 ± 0.58	81.638 ±1.43
4	F4	103.77 ± 0.85	33.56 ± 0.68	3.841 ± 2.01	75.968 ± 0.84
5	F5	68.73 ± 0.93	26.49 ± 1.95	2.936 ± 0.73	61.376 ± 2.03
6	F6	105.13 ± 0.79	35.71 ± 2.11	2.848 ± 0.59	83.864 ± 1.84
7	F7	79.22 ± 1.62	21.56 ± 1.12	4.822 ± 1.36	79.382 ± 1.44
8	F8	110.87 ± 0.94	32.24 ± 2.34	5.739 ± 0.47	85.399 ± 0.79
9	F9	99.42 ± 1.44	27.96 ± 0.76	8.265 ± 1.63	86.274 ± 1.83
10	F10	84.57 ± 0.53	36.69 ± 0.97	4.274 ± 2.07	74.288 ± 2.11
11	F11	97.32 ± 1.34	31.38 ± 1.52	0.996 ± 1.43	83.732 ± 0.68
12	F12	75.35 ± 2.01	26.55 ± 0.91	3.543 ± 1.35	81.745 ± 1.74
13	F13	60.43 ± 1.25	28.37 ± 1.32	0.254 ± 0.74	91.56 ± 1.93

and PDI of formulations have been depicted in Table 7.